Published on : Mar 07, 2017
Albany, New York, March 7, 2017: Epilepsy is a group of neurological diseases which is characterized by epileptic seizures. Epileptic seizures are occurrences that can range from short to long periods of vigorous shaking. Epilepsy is the fourth most common neurological diseases and affects people of all age group. To explore the global epilepsy market, a new report has been added to the massive portfolio of Market Research Hub’s research offerings. This report titled as “Global Epilepsy Market: Industry Analysis & Outlook (2017-2021)” provides details of the clinical benchmarks of the current market scenario and also some of the expected changes in the market. It contains an all-inclusive analysis of the global epilepsy drugs market with the study of the regional markets and players. The major trends, growth drivers as well as hindrance faced by the market players are also discussed.
Firstly, the report provides the basic overview of Epilepsy which includes definitions, causes, types of Epilepsy, treatment and Epilepsy market by drug class. Epilepsy is defined as a disease characterized by a persistent tendency to generate epileptic seizures and by the neurobiological, psychological, cognitive and social consequences of the condition. Epilepsy is divided into four major types which are as follows
- Idiopathic generalized epilepsy
- Idiopathic partial epilepsy
- Symptomatic generalized epilepsy
- Symptomatic partial epilepsy
As mentioned in the report, one of the most effective treatments for epilepsy are the antiepileptic drugs. The report further segmented the market on the basis of drug type into three major segments; first generation drugs, second generation drugs and third generation drugs. Each drug generation is described in detail. Moreover, some other treatment for the disease are brain surgery and various complementary therapies such as ketogenic diets or neural stimulation.
The major growth drivers are the development of innovative drugs, introduction of drugs in underpenetrated developing regions, occurrence of neural disorders such as tumors and meningitis, increasing healthcare spending and increasing disposable income. However, the market growth also can be stalled by tiresome drug approval process, generic erosion and a high cost of treatment. Trends such as companies concentrating on developing effective therapies for refractory epilepsy and physician’s demand of higher efficacy drugs are discussed in the report.
Click here to get more info with TOC in a PDF Format:https://www.marketresearchhub.com/enquiry.php?type=S&repid=1001568
The market is segregated into various regions, with a focus on the Americas, EMEA and APAC regions. Each region is individually explained with the current market scenario and a forecast. The four major players operating in the market are Novartis AG., Pfizer Inc., GlaxoSmithKline Plc. and UCB. Each of them is discussed along with their key financials and strategies for growth.
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org